oral glp-1 medications fda approved Wegovy Pill Becomes First Weight-Loss Drug in U.S Novo Nordisk's Wegovy Oral GLP-1
Description
Int J Mol Sci 25
Hot Prescriber Trend: GLP-1 Utilizers in Obesity Treatment Shifting to Phentermine Scripta Jun 21, 2024 2 min read Updated: Jun 24, 2024 Thanks to clinical trials that demonstrated a 12% weight-loss(1) and much buzzed about appetite-suppressing effects, the GLP-1 weight loss medications Wegovy and Zepbound, has been all over the news, and so has its high price tag

DeVries & Rosenstock, 2017

Patients with genetic testing insights achieve slightly higher maintenance rates because they can target their specific peptide pathways and metabolism patterns

GLP-1 drugs present an uncertain opportunity for healthcare and the nation Bariatric surgery volume has taken a hit, but some experts speculate a rebound is possible
